USP22 overexpression has been reported in several human cancers such as bladder cancer, colorectal cancer and oral squamous cell carcinoma and is related to the clinicopathological parameters and prognosis of many types of cancers (23–29). This evidence concerns the gene USP22 and urinary bladder cancer.